SEATTLE — September 25 — Today, 98point6 announced a partnership with BARDA DRIVe, an initiative that catalyzes the development of innovative products like 98point6’s virtual care solution to solve major health security challenges. By providing on-demand primary care, 98point6 promotes the more rapid detection and treatment of infectious diseases, reducing the spread of illness potentially caused by seeking in-person care. Through the partnership with BARDA DRIVe, 98point6 will develop a robust, real-time respiratory disease-reporting technology and a program for prevention, treatment and social distancing of influenza and respiratory illness during the influenza season. 98point6 will deploy a pilot treatment program for registered users in the Greater Seattle area. 98point6 is now part of DRIVe’s Early Notification to Act, Control, and Treat (ENACT) portfolio. Products developed under ENACT encourage early treatment and potentially reduce the spread of bacteria and viruses. Prompt attention to serious health issues can save lives, and groundbreaking technologies like 98point6 have the potential to strengthen the nation’s ability to protect Americans from health security threats. For more information, please visit www.98point6.com. About 98point6 Founded in 2015 and headquartered in Seattle, 98point6 is pioneering a new approach to primary care. By pairing deep technology with board-certified physicians, our vision is to make primary care more accessible and affordable—leading to better health and reducing the cost of care. We meet consumers where they are by offering private, text-based diagnosis and treatment via a mobile app. For employers, 98point6 increases primary care utilization among those not actively or appropriately engaged in their health—enabling earlier medical intervention and improving employee productivity. For more information about 98point6, visit www.98point6.com.